InMed Pharmaceuticals Inc (IN)

$3.94CAD

+$3.94 (+394.00%)

today (15 min delay)

About IN

InMed Pharmaceuticals, Inc. engages in the research and development of cannabinoid-based therapies and biosynthesis system for the manufacturing of pharmaceutical-grade cannabinoids. It offers pipeline of medications that target diseases with unmet medical needs, such as epidermolysis bullosa, glaucoma, and orofacial pain. The company was founded by Christopher Bogart, Sazzad Hossain, Hyder A. Khoja, and Craig D. Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.

CEO

Eric A. Adams

Headquarters

Canada

Employees

Revenue (TTM)

0

Gross Profit

Earnings

38.85%

Cash

$10M

Debt

$315K

IN related news

    Popular on Wealthsimple

      Weighting & Holdings

      Investing on autopilot

      Invest in an intelligent portfolio of low-fee funds that are designed to meet your financial goals.

      • Low Fees - Pay an annual management fee of 0.50% (or 0.40% for accounts over $100K)

      • Stay on track - We'll instantly rebalance your portfolio and put your stock dividends back to work, earning you more

      • Human advice - Our advisors will deliver sophisticated financial advice whenever you need it.

      • Easy access - Manage your accounts from anywhere with our award-winning website and mobile app

      Clock

      Start investing in 5 minutes

      1. Answer a few questions about your goals and risk tolerance
      2. We'll recommend a portfolio that's right for you
      3. Connect your bank account and make a deposit

      By clicking "Get started", you agree to Wealthsimple's Terms of Use and Privacy Policy.

      Products

      Features

      Resources

      Pricing

      Country

      Language

      Follow

      Download

      We provide investment services and other financial products through several affiliates. Our Invest and Smart Savings products are offered by Wealthsimple Inc., a registered portfolio manager in each province and territory of Canada.

      Our Trade and Save products are offered by Canadian ShareOwner Investments Inc. (ShareOwner), a registered investment dealer in each province and territory of Canada. Some clients of Wealthsimple for Advisors have accounts with Wealthsimple Advisor Services Inc. (WASI), a registered mutual fund dealer in each province and territory of Canada. Our Cash product is offered by Wealthsimple Payments Inc., a money services business registered by FINTRAC. Money in your Cash account is held in an account with ShareOwner.

      Wealthsimple Crypto is made available through the Wealthsimple Trade app, but is offered by Wealthsimple Digital Assets Inc., a virtual currency dealer money services business authorized by FINTRAC. Wealthsimple Crypto is currently not registered as a securities adviser or securities dealer. Cryptocurrencies purchased and held in an account with Wealthsimple Crypto are not protected by CIPF, the Canadian Deposit Insurance Corporation or any other investor protection insurance scheme. Any information about Wealthsimple Crypto, platform, emails, or other communications, are for informational purposes and not intended as a solicitation or advertisement for Wealthsimple Crypto.

      ShareOwner is a member of the Investment Industry Regulatory Organization of Canada (www.iiroc.ca). Customer accounts are protected by the Canadian Investor Protection Fund within specified limits. A brochure describing the nature and limits of coverage is available upon request or at (www.cipf.ca).

      WASI is a member of the Mutual Fund Dealers Association of Canada and a member of the MFDA Investor Protection Corporation.

      With any investment, your capital is at risk. The value of your portfolio with Wealthsimple can go down as well as up and you may get back less than you invest. Past performance is no guarantee of future results. Read our (investment risk disclosure) for more information.

      By using this website, you accept our (Terms of Use) and (Privacy Policy). Copyright 2020 Wealthsimple Technologies Inc. Market data by Xignite.

      IIROC Member CIPF Member MFDA Member